Israeli company PolyPid, which develops innovative Drug Carriers, has announced that it has raised $2.4 million in its series C financing round, led by Xenia Ventures. After the financing round, the company’s value raised to $17.4 million. The company has raised a total of $5.4 million to date.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments